期刊
出版社
SPIE-INT SOC OPTICAL ENGINEERING
DOI: 10.1117/12.2611590
关键词
Augmented reality (AR); prostate cancer biopsy; HoloLens; PET/CT; ultrasound imaging
资金
- U.S. National Institutes of Health (NIH) [R01CA156775, R01CA204254, R01HL140325, R21CA231911]
- Cancer Prevention and Research Institute of Texas (CPRIT) [RP190588]
Ultrasound-guided biopsy is commonly used for disease detection and diagnosis. This study aims to improve the localization of suspicious lesions by registering preoperative imaging with real-time ultrasound imaging and using augmented reality technology. The preliminary results show the feasibility of using multiple imaging modalities in an augmented reality-guided system for ultrasound-guided prostate biopsy.
Ultrasound-guided biopsy is widely used for disease detection and diagnosis. We plan to register preoperative imaging, such as positron emission tomography / computed tomography ( PET/CT) and/or magnetic resonance imaging (MRI), with real-time intraoperative ultrasound imaging for improved localization of suspicious lesions that may not be seen on ultrasound but visible on other imaging modalities. Once the image registration is completed, we will combine the images from two or more imaging modalities and use Microsoft HoloLens 2 augmented reality (AR) headset to display three-dimensional (3D) segmented lesions and organs from previously acquired images and real-time ultrasound images. In this work, we are developing a multi-modal, 3D augmented reality system for the potential use in ultrasound-guided prostate biopsy. Preliminary results demonstrate the feasibility of combining images from multiple modalities into an AR-guided system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据